Search

Search Constraints

You searched for: Author/Creator Gaggini, M.

Search Results

1. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease. (10th February 2016)

2. Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease. (10th February 2016)

3. Bile acid composition modulates insulin resistance in non-diabetic patients with NAFLD. Issue 1 (February 2018)

4. Gut–liver axis derangement due to lack of inflammasome activity leads to visceral obesity and NASH development. (15th February 2015)

5. Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD. Issue 1 (16th February 2017)

6. Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease. (February 2020)

7. Lack of NLRP3-inflammasome leads to gut-liver axis derangement and increases hepatic injury in a mouse model of NAFLD. (10th February 2016)

8. Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease. (15th February 2015)

10. OC-07A machine learning approach for the classification of NASH vs NAFL in diabetic and non-diabetic subjects reveals a strong association between liver inflammation and adipose tissue dysfunction. (October 2021)